GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
The fees, which are billed separately from physician’s services, have been around for decades but have sparked nationwide ...
WGAL Lancaster-Harrisburg on MSN48m
Flu in Pennsylvania: Doctor talks about who's most at risk, how to reduce spreadDr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.
CNET on MSN10h
Protect Your Eyes: 10 Simple Hacks for Better VisionFuture research may determine if smoking cigarettes can also cause glaucoma, Graves' eye disease, thyroid eye disease and ...
Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...
12h
Futurism on MSNEvidence Is Growing That Ozempic Can Cause BlindnessAs drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
The rapid evolution of diabetes research and management calls for a forward-thinking approach that embraces innovation to address the multifaceted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results